tirzepatide cardiovascular First Patient Dose Delivered for Lilly's Outcomes Trial-CanalLotus Biotech is a global pharmaceutical development partner providing CRDMO, China market entry, licensing and global drug supply solutions Tirzepatide in SURPASS‑CVOT: Favorable Cardiovascular
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



























